CIK 0001652130 · Large accelerated filer
Intellia Therapeutics, Inc.
Sign in to watch- Ticker
- NTLA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364785571
- Phone
- 857-285-6200
- Business address
- 400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $417,899
- in 3 filings, $395K under 10b5-1 plans
Net −$417,899. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 7 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-05-11 | Caribou Therapeutics Holdco, LLC 10% owner | Conversion | +5,244,234 | 5,593,846 | ||
| 2016-05-11 | Caribou Therapeutics Holdco, LLC 10% owner | Conversion · Founder Stock | −270,352 | 0 | ||
| 2016-05-11 | Caribou Therapeutics Holdco, LLC 10% owner | Conversion · Junior Preferred Stock | −8,110,599 | 0 |
Page 40 of 40 · 783 trades